StockData
SeaStar Medical Holding Corp logo

SeaStar Medical Holding Corp (ICUCW) stock

ICUCWNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as ICU
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026Score 3/309% above fair value
$0.01−0.01 (-34.73%)

Close on Oct 30, 2026Market cap $9.87MP/E –Yield –

Earnings

SeaStar Medical's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Nov 12, 2026
Q3 FY2026 · estimated, after the close
Revenue, Q2 FY2026
$600.00K
+100.0% on a year earlier
EPS, Q2 FY2026
-$0.91
-$0.18 a year earlier
Latest guidance
Reaffirmed
May 13, 2026 · 1 item

Quarterly results

Revenue and earnings per share from each of SeaStar Medical's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q3 FY2026ended Sep 30, 2026Nov 12, 2026Expected––––
Q2 FY2026ended Jun 30, 2026Aug 12, 2026after the close$600.00K+100.0%-$0.91Release
Q1 FY2026ended Mar 31, 2026May 13, 2026after the close$500.00K+66.7%–Release
Q4 FY2025ended Dec 31, 2025Mar 25, 2026after the close$420.00K+526.9%-$0.80Release
Q3 FY2025ended Sep 30, 2025Nov 13, 2025after the close$200.00K+196.3%–Release
Q2 FY2025ended Jun 30, 2025Aug 14, 2025before the open$300.00K–-$0.18Release
Q1 FY2025ended Mar 31, 2025May 14, 2025after the close$300.00K––Release
Q4 FY2024ended Dec 31, 2024Mar 27, 2025after the close$67.00K–-$0.90Release
Q3 FY2024ended Sep 30, 2024Nov 13, 2024after the close$67.50K––Release
Q1 FY2024ended Mar 31, 2024May 14, 2024after the close––-$0.19Release
Q3 FY2023ended Sep 30, 2023Nov 22, 2023after the close––-$0.37Release
Q2 FY2023ended Jun 30, 2023Aug 15, 2023after the close––-$0.25Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

SeaStar Medical's latest outlook for periods it has not reported yet, compared with what it said before

MetricPeriodGuidanceBeforeChangeGiven
net product revenueFY2026$2.00M$2.00MReaffirmedMay 13, 2026

Guidance history

Every forecast SeaStar Medical put in an earnings release, newest first

GivenMetricPeriodGuidanceChange
May 13, 2026net product revenueFY2026$2.00MReaffirmed
Mar 25, 2026net product revenueFY2026$2.00MNew

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.

Press releases

Releases SeaStar Medical filed with the SEC as exhibits to Form 8-K or 6-K

  1. PRESS RELEASE, DATED OCTOBER 5, 2026
    News
  2. SeaStar Medical Reports Second Quarter 2026 Financial Results and
    Results
  3. SeaStar Medical Reports First Quarter Financial Results
    Results
  4. SeaStar Medical Reports Fourth Quarter and Full Year 2025 Financial Results
    Results
  5. SeaStar Medical Announces 1-for-10 Reverse Split
    News
  6. SeaStar Medical Reports Third Quarter 2025 Financial Results and
    Results
  7. SeaStar Medical Reports DSMB Recommendation to Continue the
    News
  8. SeaStar Medical Reports Second Quarter 2025 Financial Results and
    Results
  9. SeaStar Medical Announces $4.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
    Update
  10. PRESS RELEASE DATED JULY 10, 2025
    Update
  11. SeaStar Medical Announces Positive Nasdaq Listing Determination
    Update
  12. SeaStar Medical Announces Pricing of Up to $8 Million Public Offering
    Update
  13. SeaStar Medical Reports First Quarter 2025 Financial Results and
    Results
  14. SeaStar Medical Reports Fourth Quarter and Full Year 2024 Financial Results
    Results
  15. PRESS RELEASE DATED JANUARY 31, 2025
    Update